Cargando…
Comparison of healthcare utilization among managed Medicaid individuals diagnosed with multiple sclerosis treated with emergent versus established disease modifying therapy
Background: Emerging disease-modifying therapies (DMTs) have evolved as an alternative treatment for patients with multiple sclerosis (MS). The efficacy and safety of established DMTs (interferons, glatiramer acetate, natalizumab, fingolimod and mitoxantrone) have been well studied and clinical tria...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764333/ http://dx.doi.org/10.1080/21556660.2019.1658324 |